3 years, 1 month ago

Covaxin Maker Bats for Booster Shots in India, Says Ideal After 6 Months of 2nd Dose

News 18

After several countries have begun inoculating the vulnerable population with booster shots against Covid-19, Covaxin manufacturer- Bharat Biotech CMD Krishna Ella said that a booster dose would be ideal six months after receiving the second dose of the anti-Covid vaccine. Taking about the delay in granting the EUA by the World Health Organisation for Covaxin, Ella blamed the “negative campaign” against the vaccine in India. Reportedly, he hinted at politics as a possible factor behind the negative reports, and recalled how soon after Prime Minister Narendra Modi took the Covaxin shot to express confidence in Indian science, innovation and ‘atma-nirbhar’ capabilities, it was labelled by some as a ‘BJP vaccine’ or ‘Modi vaccine’. Further in the session, Ella indicated that the nasal Covid vaccine being developed by Bharat Biotech could be taken in lieu of the second dose of Covaxin or to protect previously infected persons.

India Ella Vaccine Bharat Biotech Dose vaccine india dose 2nd bharat booster nasal ella months maker covaxin ideal bats shots biotech times

History of this topic

3 months, 3 weeks ago

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine

Hindustan Times

In a recent development, Hyderabad-based Indian Immunologicals Ltd in collaboration with Griffith University in Australia has made a significant breakthrough in COVID-19 vaccination technology. Indian Immunologicals Ltd unveils first needle-free booster vaccine “This accomplishment signifies a major step forward in our battle against COVID-19. According to the press release, the innovative vaccine sports an attenuated formulation that uses advanced codon …

4 months, 3 weeks ago

The right way to counter a poor Covaxin safety study

The Hindu

It took all of five days for the Indian Council of Medical Research to strongly criticise the poor design of the long-term safety study of Covaxin by researchers from the Banaras Hindu University, Varanasi. A publication failure that is glaring Three years after the interim data were posted as a preprint, Bharat Biotech and ICMR are yet to publish any …

7 months, 1 week ago

BHU study: Over 30 per cent of Covaxin recipients report adverse events

India TV News

A recent study conducted by researchers at Banaras Hindu University revealed that over 30% of individuals who received Bharat Biotech's Covaxin reported adverse events. The one-year follow-up study, encompassing 926 participants, shed light on the long-term safety of the BBV152 vaccine, with serious adverse events of special interest such as stroke and Guillain-Barre syndrome reported in one per cent of …

7 months, 3 weeks ago

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine

Hindustan Times

Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first." It stated that Covaxin was the "only Covid vaccine" in government of India's COVID-19 immunisation program to have conducted efficacy trials in India. "@bharatbiotech announcement - …

9 months, 2 weeks ago

Covishield more effective than Covaxin: Study

New Indian Express

BENGALURU: Covishield vaccine had higher antibody response compared to Covaxin during the pandemic, according to a study by a consortium of 11 institutions led by scientists from the National Centre for Biological Sciences, Bengaluru. In all, 691 people aged between 18 and 45, mostly from Bengaluru and Pune, were part of the study.’Immunogenicity of SARS - CoV-2 vaccines Covaxin and …

9 months, 2 weeks ago

What study on Covishield versus Covaxin vaccine reveals

The Hindu

March 07, 2024 10:59 am | Updated March 09, 2024 10:53 am IST - Bengaluru A new study by a consortium of 11 institutes, led by scientists from the National Centre for Biological Sciences, has found that the Covishield vaccine demonstrated more robust immune responses compared to Covaxin. The key findings state that Covishield, leveraging a virus vector to deliver …

10 months, 4 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

11 months, 3 weeks ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

1 year ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

1 year, 5 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

1 year, 6 months ago

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

The Hindu

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24. The vaccine will for now only be available as a booster or “precaution dose”, that is, somebody who has already been vaccinated thrice will be ineligible as the relevant …

1 year, 8 months ago

Serum Institute of India to produce 5mn Covishield doses in two months

Hindustan Times

Serum Institute of India chief executive officer Adar Poonawalla, while underlining that the current strain of Covid is mild and the demand for vaccine shots is low, said his firm will produce five to six million Covishield doses in the next two to three months and same amount of stock is already available for Covovax. According to Poonawalla, SII has …

1 year, 8 months ago

India restarts Covid vaccine production as new infections soar 30% in one day

The Independent

India is ramping up its vaccine production following a rapid surge in Covid-19 cases driven by a new subvariant dubbed Arcturus. The country recorded 10,158 news Covid cases on Thursday, a 30 per cent surge in one day, according to the federal health ministry data. The company stopped manufacturing Covishield in December 2021 due to dwindling demand and a low …

1 year, 8 months ago

India sees over 7,800 COVID cases in a day reported on April 12, 2023

The Hindu

Omicron XBB and its variants are responsible for the current surge in COVID-19 cases, but this is not a cause for worry as the severity of this variant is currently below average, with less hospitalisation, a senior Health Ministry official said on April 12. The Health Ministry source said that the current surge is not a “wave” but rather an …

1 year, 8 months ago

‘Study on covid vaccines’ efficacy soon’

Live Mint

New Delhi: The National Institute of Virology plans to conduct a study to determine the efficacy of vaccines with covid variants. Asked if there’s a need for a 4th dose, Yadav said in an interview, “Before we talk about 4th dose, we should enhance coverage of 3rd precautionary dose to enhance the immune response.” Only about 228.7 million Indians have …

1 year, 8 months ago

Covovax to be available on CoWIN as booster dose soon. Check details

Hindustan Times

In view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute’s Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. According to an official source, Singh had mentioned in his letter to the ministry that …

1 year, 8 months ago

Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults

Hindustan Times

Amid rising coronavirus cases, the Serum Institute of India has written a letter to the Union health ministry seeking the inclusion of its COVID-19 vaccine Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. The letter was written by Prakash Kumar Singh, Director, Serum Institute of India on March 27, they said. …

1 year, 9 months ago

After 113 days, India sees jump in Covid cases as 524 fresh infections surface in 24 hours

India TV News

Covid update: India witnessed a slight jump in fresh Covid cases on Sunday when the daily figure crossed over 500 to 524 after a gap of 113 days. The overall death, toll ever since pandemic first hit the country, has increased to 5,30,781 with one new fatality reported in Kerala, government data said. The number of people who have recuperated …

1 year, 10 months ago

India saved 3.4mn people through Covid-19 vaccination drive: Report

Hindustan Times

India saved at least 3.4 million lives by undertaking a nationwide Covid-19 vaccination campaign at an unprecedented scale, said a new report released by the Union health minister, Mansukh Mandaviya, on Friday, adding that the vaccination campaign also yielded a positive economic impact by preventing a loss of $18.3 billion. India started its Covid vaccination drive on January 16, 2021, …

1 year, 10 months ago

Bharat Biotech starts dispatching nasal vaccines: Why it’s a big thing for India

Live Mint

The world's first intranasal heterologous booster dose has begun to be dispatched by Bharat Biotech to hospitals, Executive Chairman Dr. Krishna Ella announced on February 5. He discussed the delivery of vaccines under the bilateral agreement between the Ella Foundation and the UW-Madison Global Health Institute for the establishment of the first-ever UW-Madison One Health Center in India for improving …

1 year, 10 months ago

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella

India TV News

COVID-19 vaccine : Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday. "We dispatched three lakh doses of the world's first intranasal COVID-19 vaccine to some hospitals two days ago," Ella said. Establishing the UW-Madison Global One Health Centre holds great significance as …

1 year, 10 months ago

Nasal vaccine at govt centres in Delhi from Feb 15

Hindustan Times

India’s first nasal vaccine for Covid-19, iNCOVACC, which was formally launched on Thursday, is likely to be made available at government centres in the national capital by mid-February, senior officials of the Delhi government said on Friday. Union health minister Mansukh Mandaviya and science and technology minister Jitendra Singh launched Bharat Biotech’s nasal Covid vaccine, iNCOVACC, on the occasion of …

1 year, 10 months ago

India launches world’s 1st intranasal Covid vaccine: Check price, availability

Hindustan Times

The world's first made-in-India intranasal Covid-19 vaccine iNCOVACC, manufactured by Bharat Biotech, was launched on Thursday as the country marked its 74th Republic Day. Union health minister Mansukh Mandaviya launched the vaccine and emphasised India's vaccine manufacturing and innovation capability, which he said is appreciated all over the world. "As the world's first intranasal Covid-19 vaccine, this is a glorious …

1 year, 10 months ago

What is nasal vaccine - iNCOVACC? All you need to know

India TV News

Covid19 nasal vaccine : Union Health Minister Mansukh Mandaviya on Friday launched Bharat Biotech's first India-made nasal Vaccine, iNCOVACC, as a booster shot for Covid19. According to Bharat Biotech, the nasal vaccine is likely to prevent infection, thus, preventing the transmission of the virus. The event saw the Union Minister of State Science & Technology; Minister of State Earth Sciences; …

1 year, 10 months ago

Centre rolls out first nasal Covid vaccine as booster

Hindustan Times

India on Thursday rolled out the first nasal vaccine against Covid-19, to be administered as a primary or booster dose for adults, potentially widening the pool of people who may take a third vaccine against the infection, cutting tertiary costs, and easing pressures on supply and storage networks. “Being the world’s first intranasal Covid-19 vaccine, this marks a glorious tribute …

1 year, 10 months ago

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine

Hindustan Times

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday. The nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's approval in November for restricted emergency use among adults as a heterologous booster dose. According to a statement issued …

1 year, 10 months ago

Private hospitals with advance orders to get intranasal COVID-19 shots soon

The Hindu

Union Health Minister Mansukh Mandaviya and Minister of Science and Technology Jitendra Singh launched first-of-it’s-kind intranasal COVID-19 vaccine iNCOVACC manufactured by Hyderabad-based Vaccine developer Bharat Biotech International Limited on January 26, 2023. It is the world’s first Intranasal vaccine for COVID to receive approval for the primary two-dose schedule, and as a heterologous booster dose, administered as nasal drops. The …

1 year, 10 months ago

India’s first intra-nasal Covid-19 vaccine iNCOVACC launched

Live Mint

Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched India's first made nasal vaccine against Covid-19 iNCOVACC. "Our nasal vaccine will be officially launched on January 26, on Republic Day," the company's chairman and managing director Krishna Ella said, participating in the 'Face-to-Face with New Frontiers in Science' segment of the IISF, organised at the …

1 year, 10 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

1 year, 11 months ago

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today

India TV News

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya will launch 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday, official sources said. According to the sources, Hyderabad-based Bharat Biotech's Intranasal heterologous booster dose is likely to be available in the market by February first week.Recently, Bharat Biotech announced iNCOVACC® as a booster dose in the country.Earlier this …

1 year, 11 months ago

Bharat Biotech’s nasal vaccine likely to be launched on Jan 26

Hindustan Times

Bhopal: Bharat Biotech’s nasal Covid-19 vaccine iNCOVACC is expected to be launched on January 26, executive chairman Krishna Ella said at an event on Saturday. “Our nasal vaccine will be officially launched on January 26 on Republic Day,” Ella told students at the Maulana Azad National Institute of Technology in Bhopal, where the India International Science Festival, 2022, is being …

1 year, 11 months ago

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26

India TV News

Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said here on Saturday. In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 …

1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

1 year, 11 months ago

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey

News 18

At least 39% of respondents have already taken the Covid vaccine booster dose, while 6% plan to take the injectable booster and 4% the nasal one, a LocalCircles survey has found. Amid the uptick in Covid in cases in China and other countries, the Centre gave nod for Bharat Biotech’s intranasal COVID vaccine iNCOVAAC as a booster dose. Director General …

1 year, 11 months ago

Braving a Viral Storm tells the tale of India’s COVID vaccine journey

The Hindu

India’s development and production of its own vaccines against COVID-19 was an important part of dealing with the pandemic, pushed by Prime Minister Narendra Modi’s view that the “entrepreneurial state” of government would bear the front-loaded risks of the effort, cushioning the private sector, according to a new book. The authors of Braving a Viral Storm: India’s Covid-19 Vaccine Story, …

1 year, 11 months ago

COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla

Firstpost

Pune: Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Poonawalla told the media that the vaccine works very well against the Omicron variant of coronavirus. Speaking to reporters on the sidelines of an event at the Bharati …

1 year, 11 months ago

Covovax vaccine will get approval in next 10-15 days, says SII CEO Poonawalla

Hindustan Times

Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Adar Poonawalla, chief executive officer of Serum Institute of India Speaking to reporters on the sidelines of an event at the Bharati Vidyapeeth University here on Sunday, the SII …

1 year, 11 months ago

Covovax to get approval as booster in 10-15 days, says SII’s Adar Poonawalla

Live Mint

As India braces for a possible rise in COVID-19 cases, a new vaccine is set to join the ranks as booster this month. Serum Institute of India's Covovax vaccine - which is effective against the Omicron strains - will get approval as a booster jab against COVID-19 in the next 10 to 15 days. All you need to know about …

1 year, 11 months ago

Second COVID-19 booster dose not required, says government sources

Firstpost

New Delhi: Based on the current Covid-19 situation in the country, there is no need to administer a second booster dose, government sources told ANI, as the Union Health Ministry data on Tuesday showed that only 134 new coronavirus cases were recorded throughout the nation in the last 24 hours with the daily positivity rate at 0.09 per cent “As …

1 year, 11 months ago

No second Covid-19 booster dose required: Report

Live Mint

There is no need to take a second booster dose against Covid-19 infection, news agency ANI reported on Tuesday citing government sources. According to the data by the Union Health Ministry, a total of 220.11 crore vaccine doses have been administered in the country, of which 95.13 crore have taken the second dose while only 22.41 crore of the population …

1 year, 11 months ago

Can Your Vaccine Protect You Against BF.7? India Isolates New Strain, Begins Study to Test Efficacy

News 18

A sample of SARS-CoV-2 virus containing the BF.7, a sub-lineage of the Omicron variant, has successfully been isolated by India to assess the efficacy of available vaccines. “Scientists are studying whether the currently available vaccines are effective in preventing infections or serious illness caused by the new sub-variant,” a source was quoted as saying. India has reported at least four …

1 year, 11 months ago

Fourth Covid vaccine unwarranted right now but increased surveillance needed: experts

Deccan Chronicle

NEW DELHI: Several countries are administering a third and even fourth Covid booster shot but India, where many fully vaccinated individuals have not taken even one, is not there yet, say experts while stressing on the need for a structured and systematic response. If that infection did not trigger enough Omicron-specific immunity none of the vaccines currently available in India …

1 year, 11 months ago

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch

Hindustan Times

Around 250 million Covid vaccines manufactured by two major Hyderabad-based units – Biological E and Bharat Biotech – are ready for dispatch in the market as soon as orders are received. Nearly 200 million Corbevax vaccine of Biological E and 50 million of Bharat Biotech's Covaxin are stockpiled at the moment. Read| Covid drills at hospitals; case count remains low …

1 year, 11 months ago

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses

News 18

Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of Covid-19 vaccines ready to dispatch as and when orders are received. According to respective company sources, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

1 year, 11 months ago

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses

Live Mint

The two major Hyderabad-based vaccine manufacturing units, Biological E and Bharat Biotech, together are holding about 250 million Covid vaccine doses ready to dispatch as and when orders are received, according to news agency PTI. Currently, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

1 year, 11 months ago

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses

India TV News

As Covid cases are increasing in the country, now focus is back on vaccination drive. According to sources- two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together have about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. Corbevax and Covaxin stocks Biological E held 200 million doses of its …

1 year, 11 months ago

Bharat Biotech’s intranasal covid vaccine priced at ₹325 for govt hospitals

Live Mint

NEW DELHI: Bharat Biotech’s intranasal covid-19 vaccine--iNCOVACC --will be available for ₹325 per dose at government hospitals, and for ₹800 in private settings, the pharma major said on Tuesday. According to the company, iNCOVACC is the world’s first intranasal vaccine for covid-19 to have received approval for a primary two-dose schedule, and as a heterologous booster dose. Clinical trials were …

1 year, 11 months ago

Rs 800 at Pvt Hosps, Rs 325 at Govt Centres: India's 1st Needle-free Nasal Vax, Now Available as Booster

News 18

A single dose of Bharat Biotech’s intranasal vaccine iNCOVACC is now available on CoWin application for Rs 800, while Rs 325 has been fixed for purchase in government facilities. Provided that private hospitals are permitted to charge up to Rs 150 as an administrative charge for every dose of the Covid-19 vaccine, one dose of this vaccine developed on a …

1 year, 11 months ago

Price of Bharat Biotech’s nasal Covid vaccine revealed. Details here

Live Mint

Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above according to reports will be available at ₹800+ GST+ hospital charges according to sources. The country’s first intranasal covid vaccine will be rolled out in the fourth week of January as a booster dose for those …

2 years ago

After Slow Start, Demand for Covid-19 Booster Shots Spikes as China's New Wave Triggers Panic in India

News 18

After recording a dull demand for Covid-19 booster shots across months, private hospitals have finally started witnessing footfall and queries to take the jabs. According to Dr Viny Kantroo, Respiratory, Critical Care and Sleep Medicine Consultant, Indraprastha Apollo Hospitals in New Delhi, “With the news of China’s Covid-19 situation, we have seen an uptick in the number of volunteers asking …

Discover Related

Health Minister launches 100-day campaign to reduce TB incidence and mortality

The Hindu

“The rate of TB decline in India has doubled from 8.3% in 2015 to 17.7% today, much ahead of the global average. Deaths due to TB have also reduced in India by 21.4% in the last 10 years,” Union Health Minister J.P. Nadda said at the launch of the intensified national ‘100 day TB elimination campaign’ on Saturday, in Haryana. …

Health India Campaign Health Minister

2 weeks, 5 days ago

Coronavirus FAQ: I didn't get the latest COVID vaccine. Should I? And if so ... when?

NPR

Coronavirus FAQ: I didn't get the latest COVID vaccine. Plus, "potentially preventing any COVID infection keeps you from being sick, getting long COVID and making someone sick who could really be at risk," says Jeffrey Townsend, a professor of evolutionary biology and head of a lab at the Yale School of Public Health that has been studying COVID throughout the …

Health Public Health Vaccines Countries Covid Infection Cdc

3 weeks, 6 days ago

HPV vaccine makers eye growth overseas

China Daily

A medical staff member injects domestically produced bivalent HPV vaccine to a girl in Lianyungang, Jiangsu province, in May 2023. According to its latest financial report, in the first three quarters, Beijing-based Wantai Biopharm, a major HPV vaccine producer in China, reported revenue of 1.95 billion yuan, down 60.8 percent year-on-year, while net profit stood at 267 million yuan, a …

China Million Yuan Hpv Bivalent Vaccine Wantai

3 weeks, 6 days ago

HPV vaccine makers eye growth overseas

China Daily

China Million Yuan Vaccine Hpv Bivalent Wantai

3 weeks, 6 days ago

HPV vaccine makers eye growth overseas

China Daily

China Million Yuan Vaccine Hpv Bivalent Wantai

4 weeks, 1 day ago

Chennai, Mumbai on high alert for flu: What you need to know

New Indian Express

Flu season in India typically occurs during the monsoon and post-monsoon months, as the increased humidity following cooler weather creates an environment conducive to the spread of viruses. Types of flu found in India In India, several strains of the flu or influenza virus are commonly found, particularly during the monsoon and post-monsoon seasons. Influenza B Influenza B viruses are …

India Respiratory Symptoms Cause Flu Shot Severe

4 weeks, 1 day ago

Wondering If It's Too Late To Get A COVID Vaccine Before Thanksgiving? Read This.

Huff Post

LOADING ERROR LOADING Thanksgiving week is here, and there’s a good chance your plans for the food-focused holiday are already in place. But if your plans to get the updated COVID-19 vaccine well before the holiday fell through, you may be wondering if it’s too late to get the shot before getting together with family and friends. Dr. David Wohl, …

Thanksgiving Vaccines Covid Cdc Shot Months Huffpost

1 month, 1 week ago

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccin

Live Mint

MUMBAI, India & HYDERABAD, India – Business Wire India PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using machine learning-enabled computational protein design, is pleased to announce that it has been selected for inclusion in the U.S. Government’s Project NextGen. As part of this initiative, the National Institute of Allergy and Infectious Diseases, part of the …

Hyderabad Infectious Diseases Candidate Vaccine Mrna Niaid Project Nextgen

1 month, 1 week ago

First bivalent mRNA vaccine candidate against RSV goes under clinical trial

China Daily

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical trial in China on Wednesday, as an adult received a shot at a clinical research center of a major Shanghai hospital. "Official figures showed that RSV caused more than 80 percent of respiratory viral infection cases in infants and young children in …

Candidate Clinical Clinical Trial Rsv Vaccine Bivalent Mrna Innorna

1 month, 1 week ago

Health Talk | How eliminating polio has been one of the major successes of India's Universal Immunisation Programme

Hindustan Times

The World Immunisation Day is observed every year on November 10th. India is a classic example of what robust immunisation coverage against a disease can achieve in the form of the country's pulse polio programme, of which vaccination was a crucial part. India rolled out the Pulse Polio Immunization Programme on October 2 1994, and according to WHO India statement, …

Health India Disease Vaccines Immunisation Programme Diseases

1 month, 2 weeks ago

Immunisation for all is Humanly Possible

Deccan Chronicle

Vaccination drive all over the world in the last half century has contributed vastly in eradicating many vaccine preventable diseases. Vaccination against 14 disease causing bugs has reducing deaths in under one year children by 40% all over the world. According to World Health Organisation, global immunisation has saved 150 million lives. Newer vaccines like HPV vaccine which protects against …

Vaccine Children World

1 month, 2 weeks ago

Don’t wait for a holiday surge. Now is a good time to get your flu and COVID-19 vaccines

Associated Press

WASHINGTON — If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. “Why not get a vaccine that’s going to help you reduce that risk?” Who needs a fall COVID-19 or flu vaccination? In addition, the CDC is recommending that people 65 and older get a second COVID-19 shot six months after their fall …

Winter Vaccination Protection Vaccines Covid Older Cdc

1 month, 2 weeks ago

Centre recommends quadrivalent flu jabs that protect against four strains amid rising cases

Live Mint

New Delhi: The government has advised health professionals to administer a type of flu jab that protects against four different strains as the onset of winter months sees the disease claim lives. The Centre said health professionals should administer the Southern Hemisphere 2024 quadrivalent vaccine, or SH24, which protects against four flu strains. The WHO recommends people take the flu …

India Vaccine Quadrivalent Flu Flu Jab

1 month, 3 weeks ago

India to undertake mega study of covid-19 samples to help prepare for future pandemics

Live Mint

New Delhi: The Department of Biotechnology plans to undertake a study of thousands of samples and clinical material collected during covid-19 to help Indian scientists understand the susceptibility of individuals and changes in metabolic activity that will be useful in fighting future pandemics. The department will give the Indian SARS-CoV-2 Genomics Consortium, a consortium of 54 laboratories, the mandate to …

India Indian Official Covid Studies Dbt Future Pandemics

1 month, 3 weeks ago

India's New Online Vaccine Portal: A Game Changer for Immunisation Coverage

Firstpost

U-WIN is an online platform in India that will revolutionise vaccine tracking and streamline the entire vaccine administration process. It will create a centralized digital record for vaccinations given to both pregnant women and children, making it easier to identify and support those who remain outside the vaccine net. The platform will also provide flexibility by allowing parents to self-register …

Law Technology Health Public Health

2 months ago

Global Pandemic Threat: 100 Days to Save Lives

Hindustan Times

A modelling study suggests that if a vaccine for SARS-CoV-2 had been developed within 100 days, an estimated 8.3 million deaths could have been averted globally. The study also estimated that productivity losses due to illness amounting to almost $1.4 trillion and $63 billion of hospitalisation costs would have been averted globally.

Government Science Law Health Talk

2 months ago

Covid vaccine: How to book a jab and who is eligible?

The Independent

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. UKHSA figures showed the admission rate for patients testing …

Health Email Nhs Health Check Vaccine Ukhsa Covid Vaccine

2 months, 3 weeks ago

California’s COVID surge is finally over. But expect another spike in the coming months

LA Times

California’s protracted summer COVID surge has finally ended, a welcome window that provides a key opportunity to prepare for yet another expected resurgence of transmission this autumn and winter, doctors say. “We have an updated COVID vaccine, an updated flu vaccine, an RSV vaccine — all of those can help protect ourselves, our families, our communities.” California New COVID subvariant …

Health Florida Risk California Long Covid Long Cdc

3 months ago

Global vaccine alliance GAVI to buy 500,000 doses of mpox vaccine

Associated Press

DAKAR, Senegal — The global vaccine alliance Gavi will buy 500,000 doses of mpox vaccine to battle outbreaks of the disease in African countries, the organization said on Wednesday. Since the beginning of the year, there have been over 25,000 confirmed mpox cases and 723 related deaths, the vast majority in Congo, and the World Health Organization declared it a …

Mpox Congo Doses Global Vaccine Gavi

3 months ago

Global vaccine alliance GAVI to buy 500,000 doses of mpox vaccine

The Independent

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy The global vaccine alliance Gavi …

Mpox Congo Doses Global Vaccine Gavi

3 months, 1 week ago

Lumpy Skin Disease vaccine will be launched soon, says govt

New Indian Express

NEW DELHI: The Central Government said that it will release vaccination for Lumpy Skin Disease on September 18. In the past two years, around 2 lakhs cattle died and millions of cattle lost their milk producing capacity due to LSD across the country. “The LSD vaccination is at commercial stage and will be released soon,” said Alka Upadhyay, Secretary, the …

Cattle Lsd Lumpy Skin

3 months, 1 week ago

What to know about the available Covid-19, flu and RSV vaccines

CNN

CNN — It’s that time of year when any cough or sniffle could be Covid-19, flu or RSV — but there are ways to fend them off. Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the …

Vaccines Cnn Covid Older Cdc Last Year Flu

3 months, 1 week ago

WHO grants first mpox vaccine approval to ramp up response to disease in Africa

Associated Press

GENEVA — The World Health Organization said Friday it has granted its first authorization for use of a vaccine against mpox in adults, calling it an important step toward fighting the disease in Africa. “This first of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in …

Africa Mpox Vaccine

3 months, 1 week ago

CDC says mpox vaccine boosters aren’t needed in the US as questions emerge around waning immunity

CNN

CNN — As a deadly mpox outbreak continues to spread in Africa and other parts of the world, questions are emerging about whether some vulnerable people in the United States may need booster doses of the mpox vaccine. “I’ve literally had people call me and say, ‘Should I get a booster, because it’s been two years?’ and my suggestion right …

Health Outbreak Risk Mpox Cnn Public Infection

3 months, 1 week ago

Bharat Biotech collaborates with US-based Alopexx to develop antimicrobial vaccine

Hindustan Times

Hyderabad-based Bharat Biotech on Wednesday announced its collaboration with US-based Alopexx Inc for development and commercialisation of the latter’s broad-spectrum anti-microbial vaccine in India and other low-income countries, which experts feel could be a game-changer in tackling the growing anti-microbial resistance threat. This collaboration aligns with our mission to provide safe, affordable, and high-quality vaccines to combat infectious diseases globally,” …

Vaccines Resistance Vaccine Infections Antimicrobial Bharat Biotech

3 months, 2 weeks ago

HPV vaccine administered to 45 girls in Visakhapatnam

The Hindu

Chaitanya Sravanthi, an NGO, organised a booster vaccination camp for women to prevent Human papillomavirus on Sunday, September 8, at the Sachivalayam in 37th Ward, opposite Mrs. AVN College. Visakhapatnam South MLA Vamsi Krishna Srinivas inaugurated the camp and appreciated Chaitanya Sravanthi’s efforts to prevent cervical cancer and create awareness among women about the vaccine. Dr. Rahaman said that administration …

Vaccine Cervical Cancer Rahaman Hpv Vaccination Chaitanya Sravanthi Visakhapatnam Chaitanya Sravanthi Hpv Vaccine

$The first 100,000 doses of mpox vaccine reach Congo. But it’s a fraction of what is needed$

3 months, 2 weeks ago

The first 100,000 doses of mpox vaccine reach Congo. But it’s a fraction of what is needed

The Hindu

The first batch of mpox vaccine arrived in Congo’s capital on Thursday, September 5, 2024, the country’s authorities said, three weeks after the World Health Organization declared mpox outbreaks in 12 African countries a global emergency. About 380,000 doses of mpox vaccines have been promised by Western partners such as the European Union and the United States, Dr. Jean Kaseya, …

Health Africa Nigeria Outbreak Congo Doses Mpox Vaccines

3 months, 2 weeks ago

U-Win, online vaccine management portal to be launched later in September: Union Health Secretary

The Hindu

Online vaccine management portal U-Win will be launched later in September to maintain a permanent digital record of vaccination and medicines of more than three crore pregnant women and almost 2.7 crore children born annually, Union Health Secretary Apurva Chandra said on Friday. The U-Win platform, a replication of the COVID-19 vaccine management system Co-WIN, is being run in a …

Health Healthcare Digital Chandra Nhrc

$The first 100,000 doses of mpox vaccine reach Congo. But it’s a fraction of what is needed$

3 months, 2 weeks ago

The first 100,000 doses of mpox vaccine reach Congo. But it’s a fraction of what is needed

Associated Press

KINSHASA, Congo — The first batch of mpox vaccine arrived in Congo’s capital on Thursday, the country’s authorities said, three weeks after the World Health Organization declared mpox outbreaks in 12 African countries a global emergency. The 100,000 doses of the MVA-BN vaccine, manufactured by the Danish company Bavarian Nordic, have been donated by the European Union through HERA, the …

Mpox Congo Mpox Vaccine

3 months, 2 weeks ago

‘Faulty’ COVID vaccine behind recruitment drive deaths: Jharkhand CM Hemant Soren

The Hindu

Jharkhand Chief Minister and Jharkhand Mukti Morcha leader Hemant Soren on Wednesday alleged that “faulty” COVID-19 vaccine doses administered by the BJP-led Union government were responsible for 12 candidates losing their lives during physical tests for an excise constable recruitment drive in the State. The Chief Minister alleged that the BJP-led government had given “faulty vaccines”, which have had a …

State Bjp Soren Covid Vaccine Deaths Jharkhand

3 months, 3 weeks ago

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration

ABC

Australia's national drug regulator is evaluating the safety and efficacy of two new COVID-19 vaccines designed to provide better protection against new variants of the virus. While there is no longer much circulation of the original JN.1 variant in Australia, Professor Esterman said the new vaccines — targeting JN.1 — would likely still prove highly effective. While TGA approval isn't …

Vaccines Covid Months Vaccine Bennett Booster Tga

3 months, 3 weeks ago

The new COVID vaccine is out — but you might not want to rush to get it

Raw Story

The FDA has approved an updated covid shot for everyone 6 months old and up, which renews a now-annual quandary for Americans: Get the shot now, with the latest covid outbreak sweeping the country, or hold it in reserve for the winter wave? “Covid is still very transmissible, very new, and people congregate inside in air-conditioned rooms during the summer,” …

Health Summer Vaccines New York Cdc Fda Vaccine

3 months, 3 weeks ago

The new COVID vaccine is here. Why these are the best times to get immunized

LA Times

With the new COVID-19 vaccinations for the 2024–25 season arriving in California and across the nation, an important question arises: When is the best time to get the shot? “Getting vaccinated now probably gives you the maximum amount of protection that you can get against what’s currently circulating, and that will last for several months, at least,” he said. “Right …

Vaccination Protection Risk California Long Covid Covid Infection

3 months, 3 weeks ago

Why is taking so long to get mpox vaccines to the epicenter of the crisis?

NPR

Why is taking so long to get mpox vaccines to the epicenter of the crisis? The U.S. and Europe have access to mpox vaccines, but the epicenter of the current mpox crisis in the Democratic Republic of the Congo has no doses yet. INSKEEP: WHO - World Health Organization - important global health organization, and they know that this disease …

Health Africa Mpox Vaccines Right Drc Npr

3 months, 3 weeks ago

Indian Immunologicals Ltd develops needle-free COVID-19 intranasal booster vaccine in collaboration with Australian university

The Hindu

Hyderabad-headquartered vaccine manufacturer Indian Immunologicals Ltd, in partnership with Griffith University, Australia has developed a needle-free intra-nasal booster vaccine against SARS-CoV-2, a press release from the company stated. According to the press release, codon de-optimisation involves decreasing the frequency of underrepresented codon pairs without changing the amino acid sequences. K. Anand Kumar, managing director, Indian Immunologicals Limited said as per …

India Vaccine

3 months, 4 weeks ago

New coronavirus vaccination round starts in the Netherlands

Dutch News

The government has launched a new coronavirus vaccination round for the over-60s and younger people with certain health conditions, and the first invitations for a jab arrived on Tuesday. Everyone over the age of 60 is being invited to have the vaccination by letter, while others considered to be at extra risk will be able to make an appointment via …

Ill

3 months, 4 weeks ago

New coronavirus vaccination round starts in the Netherlands

Dutch News

Ill

3 months, 4 weeks ago

As COVID wave wallops California, new vaccines arrive this week. Will it be a turning point?

LA Times

New COVID-19 vaccines are expected to be available as soon as this week, a promising development amid California’s potent and enduring summer wave of the disease. “I have a tremendous empathy, having seen people struggle with long COVID in their 30s and 40s, people who you might think were otherwise low-risk,” Dr. Peter Marks, the FDA’s vaccine chief, said Friday. …

Winter Coronavirus Risk California Vaccines Marks Long Covid

4 months ago

WHO caused delay in availability of Mpox vaccines in Congo

New Indian Express

There are no vaccines for mpox available in the Democratic Republic of Congo, the epicenter of a global health emergency declared last week, even though the country first asked for the shots two years ago and the manufacturers say they have supplies, The New York Times reported. Three years after the last worldwide mpox outbreak, the WHO still has neither …

Mpox Congo

4 months ago

An update on fall respiratory viruses

NPR

An update on fall respiratory viruses Health officials are planning another fall campaign designed to encourage everyone six months and older to get updated COVID and flu vaccines, but are scaling back the recommendation for RSV vaccines. And the CDC is recommending that everyone age 6 months and older get one of the new shots, you know, basically as soon …

Winter Vaccines Fall Covid Start Flu Rob

4 months ago

What To Know About The New COVID-19 Shots For 2024-2025

Huff Post

Jasmin Merdan via Getty Images You can expect to start seeing new COVID vaccines in your pharmacy and doctor's office in the coming days. The new vaccines are an update from last year’s shots and aim to keep people better protected by targeting a recently dominant COVID-19 subvariant, KP.2, which more closely resembles the subvariants that are currently making people …

Covid Last Year Guest Months Huffpost Shots

4 months ago

Eliminating TB by 2025 looks near impossible

Hindustan Times

Optimism is the madness of insisting that all is well when we are miserable. The latest WHO Global TB Report reveals that India has the world’s largest TB epidemic; at 2.6 million, the country accounts for the highest number of TB cases as well as multi-drug resistant cases. A study from Mumbai highlighted an unacceptably long average delay between a …

Health India Treatment Indian Patient Mdr Near Impossible

4 months ago

FDA approves updated COVID-19 vaccines; shots should be available in days

LA Times

With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses of the new COVID019 vaccine. U.S. regulators approved updated COVID-19 vaccines on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter too. “We strongly encourage those who are eligible to consider receiving …

Virus Fda Vaccine Moderna Updated Shots Pfizer

4 months ago

The new COVID shot is now available. Here's what you need to know

NPR

The new COVID shot is now available. "But if we can prevent people from getting serious cases that end up in emergency rooms, hospitals or worse — dead — that’s what we’re trying to do with these vaccines.” Sponsor Message On average across all age groups, the two mRNA vaccines should cut the risk of having COVID-19 by 60% to …

Health Vaccines Marks Covid Shot Months Fda

4 months ago

COVID-19 variant KP.3.1.1 predominant in US as infections continue ticking up

China Daily

LOS ANGELES - The KP.3.1.1 COVID-19 variant, now the predominant SARS-CoV-2 variant circulating in the United States, has been causing increasing infections in the country, the latest data from the US Centers for Disease Control and Prevention showed. For the two-week period ending Aug 17, KP.3.1.1 is predicted to account for between 31 percent and 43 percent of COVID-19 clinical …

Cdc Period Ending

4 months ago

Serum Institute 'hopeful' of producing Mpox vaccine, says CEO Adar Poonawalla

India TV News

The Serum Institute of India announced on Tuesday that it is actively developing a vaccine for Monkeypox, with positive results anticipated within a year. Serum Institute's vaccine development efforts Serum Institute of India is working on a Monkeypox vaccine to address the global health emergency declared by the WHO. The vaccine is expected to be ready within a year, according …

Health Global India Mpox Vaccine Serum Monkeypox

4 months ago

African health officials hopeful mpox shots will start within days as WHO says outbreak is ‘not the new Covid’

CNN

CNN — African nations could begin vaccinations against mpox within days, according to the continent’s top public health agency, as a World Health Organization official said the spread of a deadlier strain of the virus could be controlled and “was not the new Covid.” The Democratic Republic of Congo is at the epicenter of an mpox outbreak declared a global …

Africa Outbreak Mpox Covid Spread Clade Health Officials

4 months, 1 week ago

Union Health Minister Nadda reviews India’s preparedness for monkeypox

The Hindu

With the World Health Organization declaring monkeypox a Public Health Emergency of International Concern, a detailed review of developments related to monkeypox, and preparedness for it, was taken up by the Union Health Minister J.P. Nadda in a meeting with senior officials on Saturday. “In the meeting chaired by the Union Health Minister, it was decided that as a matter …

India Health Ministry Monkeypox Union Health Minister Minister Nadda

4 months, 3 weeks ago

Fighting mosquito menace with repellents, vaccines

The Hindu

Since 2007, WHO has called April 15 World Malaria Day to highlight the need for continued investment and sustained political commitment to malaria prevention and control. In 1902, Sir Ronald Ross received the Nobel Prize in Physiology/Medicine for having shown how malaria was transmitted by the bite of Anopheles mosquitoes infecting a human patient in Hyderabad suffering from malaria. The …

World Malaria Repellents Vaccines India Mosquito